Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma

Journal of Assisted Reproduction and Genetics

Volumn 28, Issue 2, 2011, Pages 167-172

  Lim, Ji Hyae ^a   Kim, Mee Jin ^a   Kim, Shin Young ^a   Kim, Hye Ok ^b   Song, Mee Jin ^c   Kim, Min Hyoung ^b   Park, So Yeon ^a   Yang, Jae Hyug ^b   Ryu, Hyun Mee ^a,b  

^a Cheil General Hospital   (South Korea)

^b Catholic Kwandong University   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

Achondroplasia; Maternal plasma; Non invasive prenatal diagnosis; QF PCR

Indexed keywords

DNA; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GENOMIC DNA;

ACHONDROPLASIA; ALLELE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FETUS; GENE MUTATION; GESTATIONAL AGE; HUMAN; MATERNAL PLASMA; NUCLEIC ACID ANALYSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUANTITATIBE FLUORESCENT POLYMERASE CHAIN REACTION; WILD TYPE;

ACHONDROPLASIA; DNA; FEMALE; GENOTYPE; HUMANS; MATERNAL-FETAL EXCHANGE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 79953325500     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-010-9489-1     Document Type: Article

References (18)

1. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78:335-42. (Pubitemid 24241100)
2. Bellus GA, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995;56:368-73.
3. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, et al. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm Res. 1996;45:108-10. (Pubitemid 26034772)
4. Trujillo-Tiebas MJ, Fenollar-Cortés M, Lorda-Sánchez I, Díaz- Recasens J, Carrillo Redondo A, Ramos-Corrales C, et al. Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience: prenatal diagnosis in FGFR3 gene. J Assist Reprod Genet. 2009;26:455-60.
5. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet. 2000;356:1170.
6. Li Y, Holzgreve W, Page-Christiaens GC, Gille JJ, Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn. 2004;24:896-8. (Pubitemid 39576805)
7. Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. Noninvasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn. 2007;27:11-7. (Pubitemid 46144334)
8. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485-7. (Pubitemid 27343304)
9. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet. 2002;360:998-1000. (Pubitemid 35284114)
10. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004;50:88-92. (Pubitemid 38125703)
11. Rijnders RJ, Van Der Luijt RB, Peters ED,Goeree JK,VanDer Schoot CE, Ploos Van Amstel JK, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn. 2003;23:1042-4. (Pubitemid 38084143)
12. Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, et al. Reliable test for prenatal prediction of fetal RhD type using plasma from RhD negative women. Prenat Diagn. 2005;25:1040-4. (Pubitemid 41745684)
13. Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S, et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn. 2007;27:824-9. (Pubitemid 47425400)
14. Cirigliano V, Ejarque M, Cañadas MP, Lloveras E, Plaja A, Perez MM, et al. Clinical application of multiplex quantitative fluorescent polymerase chain reaction (QF-PCR) for the rapid prenatal detection of common chromosome aneuploidies. Mol Hum Reprod. 2001;7:1001-6. (Pubitemid 32952183)
15. Pertl B, Kopp S, Kroisel PM, Tului L, Brambati B, Adinolfi M. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet. 1999;36:300-3. (Pubitemid 29161062)
16. Schmidt W, Jenderny J, Hecher K, Hackelöer BJ, Kerber S, Kochhan L, et al. Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol Hum Reprod. 2000;6:855-60.
17. González-González C, Garcia-Hoyos M, Trujillo-Tiebas MJ, Lorda-Sanchez I, de Alba MR, Infantes F, et al. Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience. J Histochem Cytochem. 2005;53:307-14. (Pubitemid 40344063)
18. González-González MC, Garcia-Hoyos M, Trujillo-Tiebas MJ, Bustamante Aragonés A, Rodriguez de Alba M, Diego Alvarez D, et al. Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet. 2008;25:477-81.